Letourneau Consulting

Principal-led technical advisory

Strategic technical leadership for complex life-science programs.

Letourneau Consulting works with biopharma, combination product, and diagnostic programs where the decisions matter most: clinical readiness, risk management, design transfer, and acquisition integration.

Email Letourneau Consulting

Advisory focus areas

Across program interfaces.

The focus areas below require technical judgment that extends beyond a single function.

Clinical readiness and late-stage program risk

Before a major milestone, Letourneau Consulting evaluates whether the technical documentation, objective evidence, and cross-functional dependencies support the program’s next step. The work identifies issues requiring leadership attention and distinguishes immediate milestone risks from activities that can proceed on a longer timeline. This enables teams to prioritize the work needed to accelerate clinical readiness.

Technical diligence through integration

Technical diligence identifies the risks that require attention during an acquisition and establishes priorities for the transition. Those findings reduce integration friction by informing structured knowledge transfer and clear ownership of post-close actions. This preserves development continuity as leadership moves from transaction assessment to post-close execution.

Complex combination product development

Combination product development depends on coordination among cross-functional teams. Letourneau Consulting provides senior technical leadership across drug, device, quality, and regulatory interfaces. The work integrates design controls and risk management with the development decisions that shape clinical and commercial readiness. This alignment reduces avoidable rework and keeps development focused on the program’s critical priorities.

Compliance gap assessment and remediation

Regulatory and quality issues often reveal compliance gaps with implications beyond the immediate program. The assessment establishes a defensible basis for immediate mitigation and longer-term remediation. The resulting priorities enable leadership teams to assign ownership and direct the response with confidence.

Founder and principal

Experience bridging critical functions.

Letourneau Consulting is led by its founder, Nicolas Letourneau, PhD, with more than 15 years across international biopharma, medical device, diagnostic, drug delivery, and combination product development and manufacturing.

That experience spans several high-consequence program settings. Dr. Letourneau has driven clinical readiness, coordinated international partners and manufacturing sites, and protected integration continuity for late-stage injectable combination product programs. He has led complex regulatory and quality assessments and directed the resulting remediation. His post-acquisition work has advanced manufacturing readiness and established QC processes during organizational transitions.

That breadth allows Dr. Letourneau to see how decisions in one area affect the program as a whole. His work clarifies the technical issues and the path to resolution. The result is a technically defensible assessment with clear, actionable recommendations.